| SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | HAEMONETICS CORP | 3,792,684 | 7.2% | EDGAR |
| SC 13G/A | 2018-01-19 | BlackRock Inc. | HAEMONETICS CORP | 6,670,988 | 12.6% | EDGAR |
| SC 13G/A | 2017-09-11 | PRICE T ROWE ASSOCIATES INC /MD/ | HAEMONETICS CORP | 2,700,212 | 5.1% | EDGAR |
| SC 13G | 2017-02-15 | Black Creek Investment Management Inc. | HAEMONETICS CORP | 1,118,613 | 2.2% | EDGAR |
| SC 13G/A | 2017-02-13 | VANGUARD GROUP INC | HAEMONETICS CORP | 4,362,238 | 8.4% | EDGAR |
| SC 13G | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | HAEMONETICS CORP | 3,418,261 | 6.6% | EDGAR |
| SC 13G/A | 2017-02-07 | PRICE T ROWE ASSOCIATES INC /MD/ | HAEMONETICS CORP | 5,401,931 | 10.4% | EDGAR |
| SC 13G/A | 2017-01-12 | BlackRock Inc. | HAEMONETICS CORP | 5,890,641 | 11.4% | EDGAR |
| SC 13G/A | 2016-09-09 | BlackRock Inc. | HAEMONETICS CORP | 5,224,978 | 10.2% | EDGAR |
| SC 13G/A | 2016-06-10 | PRICE T ROWE ASSOCIATES INC /MD/ | HAEMONETICS CORP | 5,377,400 | 10.5% | EDGAR |
| SC 13G | 2016-02-16 | Black Creek Investment Management Inc. | HAEMONETICS CORP | 2,586,691 | 5.1% | EDGAR |
| SC 13G | 2016-02-12 | PRICE T ROWE ASSOCIATES INC /MD/ | HAEMONETICS CORP | 2,673,780 | 5.2% | EDGAR |
| SC 13G/A | 2016-02-11 | VANGUARD GROUP INC | HAEMONETICS CORP | 3,836,928 | 7.6% | EDGAR |
| SC 13G/A | 2016-02-09 | Neuberger Berman Group LLC | HAEMONETICS CORP | 2,387,525 | 4.7% | EDGAR |
| SC 13G/A | 2016-01-26 | BlackRock Inc. | HAEMONETICS CORP | 4,790,386 | 9.4% | EDGAR |
| SC 13G/A | 2015-02-11 | VANGUARD GROUP INC | HAEMONETICS CORP | 3,479,732 | 6.8% | EDGAR |
| SC 13G/A | 2015-02-11 | Neuberger Berman Group LLC | HAEMONETICS CORP | 4,889,723 | 9.5% | EDGAR |
| SC 13G/A | 2015-01-22 | BlackRock Inc. | HAEMONETICS CORP | 4,471,709 | 8.7% | EDGAR |
| SC 13G/A | 2014-02-12 | Neuberger Berman Group LLC | HAEMONETICS CORP | 5,724,923 | 11.1% | EDGAR |
| SC 13G/A | 2014-02-11 | VANGUARD GROUP INC | HAEMONETICS CORP | 3,399,584 | 6.6% | EDGAR |